-
Sweeping new changes have been made to the guidelines for prevention of endocarditis in patients undergoing dental procedures.
-
-
The primary care physician is often asked to deal with foot pain. This issue covers many of the common chronic and acute conditions that plague patients and provides differential diagnoses and therapeutic approaches.
-
-
The FDA has approved a new combination product for the treatment of type 2 diabetes mellitus. Sitagliptin, the recently approved dipeptidyl peptidase-4 (DPP-4) inhibitor is combined with metformin in two different dose configurations. Sitagliptin/metformin is marketed by Merck & Co., Inc as Janumet.
-
Quinolone-resistant neisseria gonorrhea (QRNG) continues to spread with alarming frequency across the United States. Quinolones were first recommended for the treatment of GC by the CDC in 1986.
-
High dose PPI infusion prior to endoscopy accelerated resolution of the signs of ulcer bleeding and significantly reduced the need for endoscopic hemostasis therapy.
-
There is a surge of coronary deaths following influenza epidemics, which strengthens the importance of flu vaccinations for those at risk for cardiovascular events.
-
Hospital legends about the relative availability (or unavailability) of services/personnel on weekends vs weekdays often lead to jocularity about the wisdom of choosing one's day to be admitted to the hospital carefully!
-
Occipital nerve stimulation appears to decrease the cluster pain and attack frequency in most, but not all, patients with chronic drug-resistant cluster headaches.